Surgery Websites
Department of Surgery »  Faculty »  General Surgery »  Kenzo Hirose, M.D.
Kenzo Hirose, M.D.

Kenzo Hirose, M.D.

Associate Professor of Surgery
Division of General Surgery
Associate Director,  General Surgery Residency Program

Contact Information

Phone: (415) 502-5577
Fax: (415) 502-2236
Kenzo.Hirose@ucsf.edu

 
Open Popup
  • 1995, AB, Harvard University, Biochemical Sciences
  • 1999, MD, Harvard Medical School
  • 2000, Internship, University of California, San Francisco, General Surgery
  • 2006, Residency, University of California, San Francisco, General Surgery
  • 2007, Fellowship, Cleveland Clinic Foundation, Liver Transplantation
  • 2008, Fellowship, Cleveland Clinic Foundation, Hepatobiliary Surgery
  • American Board of Surgery
  • Hepatobiliary and Pancreas Surgery Program
  • Bile Duct Cancer (Cholangiocarcinoma)
  • Bile Duct Injuries
  • Bile Duct Strictures
  • Bridging Therapies to Downstage HCC pre-Liver Transplant
  • Choledochal Cysts
  • Gallbladder Cancer
  • Gastrointestinal Carcinoid Tumor
  • Gastrointestinal Stromal Tumor (GIST)
  • Liver Cancer (Hepatocellular Carcinoma)
  • Liver Cysts
  • Liver Metastases
  • Minimally Invasive Liver & Pancreas Surgery
  • Pancreatic Cancer
  • Pancreatic Cysts
  • Pancreatic Neuroendocrine (Islet Cell) Tumors
  • Soft Tissue Sarcomas
  • Stomach (Gastric) Cancer

Dr. Kenzo Hirose is a general surgeon specializing in benign and malignant conditions of the liver, pancreas and bile duct. He has a special interest in minimally invasive surgical techniques and conducts research in patient outcomes after surgery.   

Dr. Kenzo Hirose received his medical degree from Harvard Medical school. He did his residency in general surgery at the University of California, San Francisco and his Hepatopancreatobiliary Fellowship at the Cleveland Clinic. 

Most recent publications from a total of 26
  1. Bongiovanni T, Hansen K, Lancaster E, O'Sullivan P, Hirose K, Wick E. Adopting best practices in post-operative analgesia prescribing in a safety-net hospital: Residents as a conduit to change. Am J Surg. 2019 Dec 21. View in PubMed
  2. Kasai Y, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Harun N, Kim MO, Warren RS, Bergsland EK, Nakakura EK. Residual tumor volume discriminates prognosis after surgery for neuroendocrine liver metastasis. J Surg Oncol. 2019 Dec 11. View in PubMed
  3. Kasai Y, Mahuron K, Hirose K, Corvera CU, Kim GE, Hope TA, Shih BE, Warren RS, Bergsland EK, Nakakura EK. Prognostic impact of a large mesenteric mass >2?cm in ileal neuroendocrine tumors. J Surg Oncol. 2019 Dec; 120(8):1311-1317. View in PubMed
  4. Lancaster E, Inglis-Arkell C, Hirose K, Seib CD, Wick E, Sosa JA, Duh QY. Variability in Opioid-Prescribing Patterns in Endocrine Surgery and Discordance With Patient Use. JAMA Surg. 2019 Aug 14. View in PubMed
  5. Lancaster E, Bongiovanni T, Lin J, Croci R, Wick E, Hirose K. Residents as Key Effectors of Change in Improving Opioid Prescribing Behavior. J Surg Educ. 2019 Nov - Dec; 76(6):e167-e172. View in PubMed
  6. Fan CJ, Hirose K, Walsh CM, Quartuccio M, Desai NM, Singh VK, Kalyani RR, Warren DS, Sun Z, Hanna MN, Makary MA. Laparoscopic Total Pancreatectomy With Islet Autotransplantation and Intraoperative Islet Separation as a Treatment for Patients With Chronic Pancreatitis. JAMA Surg. 2017 06 01; 152(6):550-556. View in PubMed
  7. Dogeas E, Cameron JL, Wolfgang CL, Hirose K, Hruban RH, Makary MA, Pawlik TA, Choti MA. Duodenal and Ampullary Carcinoid Tumors: Size Predicts Necessity for Lymphadenectomy. J Gastrointest Surg. 2017 08; 21(8):1262-1269. View in PubMed
  8. Moran RA, Jalaly NY, Kamal A, Rao S, Klapheke R, James TW, Kambhampati S, Makary MA, Hirose K, Kumbhari V, Stein EM, Khashab MA, Lennon AM, Kalloo AN, Zaheer A, Hernaez R, Singh VK. Ileus is a predictor of local infection in patients with acute necrotizing pancreatitis. Pancreatology. 2016 Nov - Dec; 16(6):966-972. View in PubMed
  9. Poruk KE, Lin JA, Cooper MA, He J, Makary MA, Hirose K, Cameron JL, Pawlik TM, Wolfgang CL, Eckhauser F, Weiss MJ. A novel, validated risk score to predict surgical site infection after pancreaticoduodenectomy. HPB (Oxford). 2016 11; 18(11):893-899. View in PubMed
  10. Hicks CW, Tosoian JJ, Craig-Schapiro R, Valero V, Cameron JL, Eckhauser FE, Hirose K, Makary MA, Pawlik TM, Ahuja N, Weiss MJ, Wolfgang CL. Early hospital readmission for gastrointestinal-related complications predicts long-term mortality after pancreatectomy. Am J Surg. 2015 Oct; 210(4):636-42.e1. View in PubMed
  11. View All Publications
Publications provided by UCSF Profiles, powered by CTSI at UCSF. View profile of Kenzo Hirose, M.D.
Please note: UCSF Profiles publications are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact CTSI for help.

 

Site Directory
    X